 | Form 4 Filings | Insider Buys | Significant Buys | Penny Stocks Insider Buying | Insider Sales |
| Insider Buy Sell Ratios | Stock Options | Insider Trading Stock Screener | Insider Trading Graph View | Insider Watch |
Insider Trading - AKCEA THERAPEUTICS Inc (AKCA)
| | "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise" - Peter Lynch What is insider trading>> |
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2020-03-23 Sale | 2020-03-25 4:41 pm | AKCEA THERAPEUTICS Inc | AKCA | McDevitt Damien CEO | 9,417 | $11.75 | $110,649 | 245,783 (Direct) | View |
| 2020-03-23 Sale | 2020-03-25 4:42 pm | AKCEA THERAPEUTICS Inc | AKCA | O'Dea Louis Chief Medical Officer | 3,198 | $11.75 | $37,579 | 61,602 (Direct) | View |
| 2020-03-23 Sale | 2020-03-25 4:43 pm | AKCEA THERAPEUTICS Inc | AKCA | Jenne Kyle Chief Commercial Officer | 779 | $11.75 | $9,153 | 52,732 (Direct) | View |
| 2020-03-23 Sale | 2020-03-25 4:44 pm | AKCEA THERAPEUTICS Inc | AKCA | Patterson Joshua F. General Counsel | 335 | $11.76 | $3,938 | 14,614 (Direct) | View |
| 2020-07-17 Sale | 2020-07-20 5:18 pm | AKCEA THERAPEUTICS Inc | AKCA | Patterson Joshua F. General Counsel | 263 | $12.5 | $3,288 | 26,851 (Direct) | View |
| 2020-09-22 Sale | 2020-09-24 4:19 pm | AKCEA THERAPEUTICS Inc | AKCA | McDevitt Damien CEO | 8,709 | $18.12 | $157,807 | 242,978 (Direct) | View |
| 2020-09-22 Sale | 2020-09-24 4:21 pm | AKCEA THERAPEUTICS Inc | AKCA | Jenne Kyle Chief Commercial Officer | 720 | $18.12 | $13,046 | 52,012 (Direct) | View |
| 2020-09-22 Sale | 2020-09-24 4:25 pm | AKCEA THERAPEUTICS Inc | AKCA | Patterson Joshua F. General Counsel | 319 | $18.12 | $5,780 | 26,532 (Direct) | View |
| 2020-10-10 Purchase | 2020-10-14 4:05 pm | AKCEA THERAPEUTICS Inc | AKCA | IONIS PHARMACEUTICALS INC 10% Owner | 21,237,716 | $18.15 | $385,464,537 | 98,322,400 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2020-02-12 Option Award | 2020-02-13 4:47 pm | N/A 2030-02-11 | AKCEA THERAPEUTICS Inc | AKCA | Salzman Amber Director | 53,000 | $17.94 | 53,000 (Direct) | View |
| 2020-03-19 Option Award | 2020-03-23 4:22 pm | N/A N/A | AKCEA THERAPEUTICS Inc | AKCA | McDevitt Damien CEO | 55,200 | $0 | 200,000 (Direct) | View |
| 2020-03-19 Option Award | 2020-03-23 4:22 pm | N/A 2030-03-18 | AKCEA THERAPEUTICS Inc | AKCA | McDevitt Damien CEO | 109,800 | $12.76 | 200,000 (Direct) | View |
| 2020-03-19 Option Award | 2020-03-23 4:22 pm | N/A 2030-03-18 | AKCEA THERAPEUTICS Inc | AKCA | McDevitt Damien CEO | 200,000 | $12.76 | 200,000 (Direct) | View |
| 2020-03-19 Option Award | 2020-03-23 4:29 pm | N/A N/A | AKCEA THERAPEUTICS Inc | AKCA | Patterson Joshua F. General Counsel | 3,780 | $0 | 7,500 (Direct) | View |
| 2020-03-19 Option Award | 2020-03-23 4:29 pm | N/A 2030-03-18 | AKCEA THERAPEUTICS Inc | AKCA | Patterson Joshua F. General Counsel | 7,500 | $12.76 | 7,500 (Direct) | View |
| 2020-03-19 Option Award | 2020-03-23 4:32 pm | N/A N/A | AKCEA THERAPEUTICS Inc | AKCA | O'Dea Louis Chief Medical Officer | 16,800 | $0 | 34,200 (Direct) | View |
| 2020-03-19 Option Award | 2020-03-23 4:32 pm | N/A 2030-03-18 | AKCEA THERAPEUTICS Inc | AKCA | O'Dea Louis Chief Medical Officer | 34,200 | $12.76 | 34,200 (Direct) | View |
| 2020-03-19 Option Award | 2020-03-23 4:34 pm | N/A N/A | AKCEA THERAPEUTICS Inc | AKCA | Jenne Kyle Chief Commercial Officer | 16,800 | $0 | 34,200 (Direct) | View |
| 2020-03-19 Option Award | 2020-03-23 4:34 pm | N/A 2030-03-18 | AKCEA THERAPEUTICS Inc | AKCA | Jenne Kyle Chief Commercial Officer | 34,200 | $12.76 | 34,200 (Direct) | View |
| 2020-03-19 Option Award | 2020-03-23 4:35 pm | N/A N/A | AKCEA THERAPEUTICS Inc | AKCA | Howarth Alex G. COO | 16,800 | $0 | 34,200 (Direct) | View |
| 2020-03-19 Option Award | 2020-03-23 4:35 pm | N/A 2030-03-18 | AKCEA THERAPEUTICS Inc | AKCA | Howarth Alex G. COO | 34,200 | $12.76 | 34,200 (Direct) | View |
| 2020-03-19 Option Award | 2020-03-31 8:41 pm | N/A N/A | AKCEA THERAPEUTICS Inc | AKCA | McDevitt Damien CEO | 60,000 | $0 | 120,000 (Direct) | View |
| 2020-03-19 Option Award | 2020-03-31 8:41 pm | N/A 2030-03-18 | AKCEA THERAPEUTICS Inc | AKCA | McDevitt Damien CEO | 120,000 | $12.76 | 120,000 (Direct) | View |
| 2020-04-13 Option Award | 2020-04-15 4:58 pm | N/A 2030-04-12 | AKCEA THERAPEUTICS Inc | AKCA | KLEIN JOSEPH III Director | 26,400 | $16.14 | 26,400 (Direct) | View |
| 2020-04-13 Option Award | 2020-04-15 5:05 pm | N/A 2030-04-12 | AKCEA THERAPEUTICS Inc | AKCA | Hochberg Elaine Director | 26,400 | $16.14 | 26,400 (Direct) | View |
| 2020-04-13 Option Award | 2020-04-15 5:09 pm | N/A 2030-04-12 | AKCEA THERAPEUTICS Inc | AKCA | Yanni Barbara Director | 26,400 | $16.14 | 26,400 (Direct) | View |
| 2020-04-13 Option Award | 2020-04-15 5:13 pm | N/A 2030-04-12 | AKCEA THERAPEUTICS Inc | AKCA | YANG MICHAEL J. Director | 26,400 | $16.14 | 26,400 (Direct) | View |
| 2020-04-13 Option Award | 2020-04-15 5:16 pm | N/A 2030-04-12 | AKCEA THERAPEUTICS Inc | AKCA | SMITH SANDFORD D Director | 26,400 | $16.14 | 26,400 (Direct) | View |
| 2020-04-13 Option Award | 2020-04-15 5:24 pm | N/A 2030-04-12 | AKCEA THERAPEUTICS Inc | AKCA | Salzman Amber Director | 26,400 | $16.14 | 26,400 (Direct) | View |
| 2020-04-13 Option Award | 2020-04-15 5:28 pm | N/A 2030-04-12 | AKCEA THERAPEUTICS Inc | AKCA | PARSHALL B LYNNE Director | 26,400 | $16.14 | 26,400 (Direct) | View |
| 2020-04-15 Option Award | 2020-04-15 5:30 pm | N/A N/A | AKCEA THERAPEUTICS Inc | AKCA | Patterson Joshua F. General Counsel | 12,500 | $0 | 27,114 (Direct) | View |
| 2020-05-18 Option Award | 2020-05-19 5:41 pm | N/A N/A | AKCEA THERAPEUTICS Inc | AKCA | PRICE MICHAEL DENNIS CFO | 50,000 | $0 | 300,000 (Direct) | View |
| 2020-05-18 Option Award | 2020-05-19 5:41 pm | N/A 2030-05-17 | AKCEA THERAPEUTICS Inc | AKCA | PRICE MICHAEL DENNIS CFO | 300,000 | $14.78 | 300,000 (Direct) | View |
| 2020-07-09 Option Award | 2020-07-10 5:31 pm | N/A N/A | AKCEA THERAPEUTICS Inc | AKCA | Andrews William T. Chief Medical Officer | 37,500 | $0 | 250,000 (Direct) | View |
| 2020-07-09 Option Award | 2020-07-10 5:31 pm | N/A 2030-07-08 | AKCEA THERAPEUTICS Inc | AKCA | Andrews William T. Chief Medical Officer | 250,000 | $13.29 | 250,000 (Direct) | View |
| 2020-08-31 Option Award | 2020-09-02 4:20 pm | N/A N/A | AKCEA THERAPEUTICS Inc | AKCA | McDevitt Damien CEO | 1,104 | $14.4 | 251,687 (Direct) | View |
| 2020-10-12 Disposition | 2020-10-13 3:30 pm | N/A 2030-04-12 | AKCEA THERAPEUTICS Inc | AKCA | PARSHALL B LYNNE Director | 26,400 | $2.01 | 0 (Direct) | View |
| 2020-10-12 Disposition | 2020-10-13 3:34 pm | N/A 2027-06-04 | AKCEA THERAPEUTICS Inc | AKCA | Hochberg Elaine Director | 52,837 | $5.94 | 0 (Direct) | View |
| 2020-10-12 Disposition | 2020-10-13 3:34 pm | N/A 2030-04-12 | AKCEA THERAPEUTICS Inc | AKCA | Hochberg Elaine Director | 26,400 | $2.01 | 0 (Direct) | View |
| 2020-10-12 Disposition | 2020-10-13 3:37 pm | N/A 2030-04-12 | AKCEA THERAPEUTICS Inc | AKCA | KLEIN JOSEPH III Director | 26,400 | $2.01 | 0 (Direct) | View |
| 2020-10-12 Disposition | 2020-10-13 3:39 pm | N/A 2030-02-11 | AKCEA THERAPEUTICS Inc | AKCA | Salzman Amber Director | 53,000 | $0.21 | 0 (Direct) | View |
| 2020-10-12 Disposition | 2020-10-13 3:39 pm | N/A 2030-04-12 | AKCEA THERAPEUTICS Inc | AKCA | Salzman Amber Director | 26,400 | $2.01 | 0 (Direct) | View |
| 2020-10-12 Disposition | 2020-10-13 3:42 pm | N/A 2027-06-04 | AKCEA THERAPEUTICS Inc | AKCA | SMITH SANDFORD D Director | 52,837 | $5.94 | 0 (Direct) | View |
| 2020-10-12 Disposition | 2020-10-13 3:42 pm | N/A 2030-04-12 | AKCEA THERAPEUTICS Inc | AKCA | SMITH SANDFORD D Director | 26,400 | $2.01 | 0 (Direct) | View |
| 2020-10-12 Disposition | 2020-10-13 3:45 pm | N/A 2030-04-12 | AKCEA THERAPEUTICS Inc | AKCA | YANG MICHAEL J. Director | 26,400 | $2.01 | 0 (Direct) | View |
| 2020-10-12 Disposition | 2020-10-13 3:50 pm | N/A 2030-04-12 | AKCEA THERAPEUTICS Inc | AKCA | Yanni Barbara Director | 26,400 | $2.01 | 0 (Direct) | View |
| 2020-10-12 Equity Swap | 2020-10-13 3:54 pm | N/A N/A | AKCEA THERAPEUTICS Inc | AKCA | McDevitt Damien CEO | 242,978 | $18.15 | 0 (Direct) | View |
| 2020-10-12 Disposition | 2020-10-13 3:54 pm | N/A 2030-03-18 | AKCEA THERAPEUTICS Inc | AKCA | McDevitt Damien CEO | 120,000 | $5.39 | 0 (Direct) | View |
| 2020-10-12 Disposition | 2020-10-13 3:54 pm | N/A 2030-03-18 | AKCEA THERAPEUTICS Inc | AKCA | McDevitt Damien CEO | 200,000 | $5.39 | 0 (Direct) | View |
| 2020-10-12 Equity Swap | 2020-10-13 3:56 pm | N/A N/A | AKCEA THERAPEUTICS Inc | AKCA | Andrews William T. Chief Medical Officer | 37,500 | $18.15 | 0 (Direct) | View |
| 2020-10-12 Disposition | 2020-10-13 3:56 pm | N/A 2030-07-08 | AKCEA THERAPEUTICS Inc | AKCA | Andrews William T. Chief Medical Officer | 250,000 | $4.86 | 0 (Direct) | View |
| 2020-10-12 Equity Swap | 2020-10-13 3:58 pm | N/A N/A | AKCEA THERAPEUTICS Inc | AKCA | Howarth Alex G. COO | 66,800 | $18.15 | 0 (Direct) | View |
| 2020-10-12 Disposition | 2020-10-13 3:58 pm | N/A 2029-12-01 | AKCEA THERAPEUTICS Inc | AKCA | Howarth Alex G. COO | 300,000 | $0.21 | 0 (Direct) | View |
| 2020-10-12 Disposition | 2020-10-13 3:58 pm | N/A 2030-03-18 | AKCEA THERAPEUTICS Inc | AKCA | Howarth Alex G. COO | 34,200 | $5.39 | 0 (Direct) | View |
| 2020-10-12 Equity Swap | 2020-10-13 3:59 pm | N/A N/A | AKCEA THERAPEUTICS Inc | AKCA | Jenne Kyle Chief Commercial Officer | 52,012 | $18.15 | 0 (Direct) | View |
| 2020-10-12 Disposition | 2020-10-13 3:59 pm | N/A 2027-06-04 | AKCEA THERAPEUTICS Inc | AKCA | Jenne Kyle Chief Commercial Officer | 143,374 | $5.94 | 0 (Direct) | View |
| 2020-10-12 Disposition | 2020-10-13 3:59 pm | N/A 2027-06-04 | AKCEA THERAPEUTICS Inc | AKCA | Jenne Kyle Chief Commercial Officer | 32,751 | $5.94 | 0 (Direct) | View |
| 2020-10-12 Disposition | 2020-10-13 3:59 pm | N/A 2028-01-01 | AKCEA THERAPEUTICS Inc | AKCA | Jenne Kyle Chief Commercial Officer | 299 | $0.77 | 0 (Direct) | View |
| 2020-10-12 Disposition | 2020-10-13 3:59 pm | N/A 2028-01-01 | AKCEA THERAPEUTICS Inc | AKCA | Jenne Kyle Chief Commercial Officer | 13,701 | $0.77 | 0 (Direct) | View |
| 2020-10-12 Disposition | 2020-10-13 3:59 pm | N/A 2030-03-18 | AKCEA THERAPEUTICS Inc | AKCA | Jenne Kyle Chief Commercial Officer | 34,200 | $5.39 | 0 (Direct) | View |
| 2020-10-12 Equity Swap | 2020-10-13 4:02 pm | N/A N/A | AKCEA THERAPEUTICS Inc | AKCA | Patterson Joshua F. General Counsel | 26,532 | $18.15 | 0 (Direct) | View |
| 2020-10-12 Disposition | 2020-10-13 4:02 pm | N/A 2030-01-01 | AKCEA THERAPEUTICS Inc | AKCA | Patterson Joshua F. General Counsel | 13,750 | $1.16 | 0 (Direct) | View |
| 2020-10-12 Disposition | 2020-10-13 4:02 pm | N/A 2030-03-18 | AKCEA THERAPEUTICS Inc | AKCA | Patterson Joshua F. General Counsel | 7,500 | $5.39 | 0 (Direct) | View |
| 2020-10-12 Equity Swap | 2020-10-13 4:04 pm | N/A N/A | AKCEA THERAPEUTICS Inc | AKCA | PRICE MICHAEL DENNIS CFO | 50,000 | $18.15 | 0 (Direct) | View |
| 2020-10-12 Disposition | 2020-10-13 4:04 pm | N/A 2030-05-17 | AKCEA THERAPEUTICS Inc | AKCA | PRICE MICHAEL DENNIS CFO | 300,000 | $3.37 | 0 (Direct) | View |